743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.77%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.97%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-10.94%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-10.94%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-15.35%
Negative net income growth while BIDU stands at 395.81%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.23%
Negative EPS growth while BIDU is at 397.91%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-14.95%
Negative diluted EPS growth while BIDU is at 390.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.42%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.38%
Reduced diluted shares while BIDU is at 1.50%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-12.81%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-15.46%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
2955.33%
10Y revenue/share CAGR above 1.5x BIDU's 1096.54%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
389.16%
5Y revenue/share CAGR above 1.5x BIDU's 82.85%. David Dodd would look for consistent product or market expansions fueling outperformance.
123.77%
3Y revenue/share CAGR above 1.5x BIDU's 39.32%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
2928.23%
OCF/share CAGR of 2928.23% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
312.83%
Positive OCF/share growth while BIDU is negative. John Neff might see a comparative advantage in operational cash viability.
59.35%
3Y OCF/share CAGR of 59.35% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
3378.45%
Net income/share CAGR 1.25-1.5x BIDU's 2382.79%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
451.58%
Below 50% of BIDU's 1227.58%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
94.84%
Below 50% of BIDU's 296.76%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
185.16%
5Y equity/share CAGR is in line with BIDU's 187.11%. Walter Schloss would see parallel mid-term profitability and retention policies.
76.17%
3Y equity/share CAGR at 75-90% of BIDU's 91.10%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.34%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
2.64%
Asset growth well under 50% of BIDU's 14.02%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.62%
Under 50% of BIDU's 24.83%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
9.01%
Debt growth far above BIDU's 0.11%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-0.21%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-8.49%
We cut SG&A while BIDU invests at 2.96%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.